DuPont de Nemours, Inc. · NYSE:DD
DuPont de Nemours — DuPont — Interschutz Conference 2005
18 slides from DuPont de Nemours's conference presentation, Jun 10, 2005
Slide 1: DuPont Fluorotelomer and AFFF Agents Update
SHK 10June2005 DuPont Fluorotelomer and AFFF Agents Update Presented at Interschutz Conference 10 June 2005 Hanover, Germany Dr. Martial Pabon & Dr. Stephen Korzeniowski
Slide 2: Presentation Agenda
SHK 10June2005 Presentation Agenda • Telomer Chemistry and Manufacturing – New Process Developments • New Developments in DuPont on PFOA – Worker Health Study – Consumer Article Study • AFFF Surfactant Toxicology – Developmental Toxicity Study Results • Degradation Studies and Life-Cycle Analysis •
Slide 3: DuPont Fluorotelomer-Based Products
SHK 10June2005 DuPont Fluorotelomer-Based Products CF2=CF2 TFE Raw Materials Surfactants F(CF2CF2)nI Telomer A Iodide • Phosphate n = 2-8 • Ethoxylate Even Carbon Number, Straight Chain • Betaine • Primarily F(CF2)6- Based F(CF2CF2)nCH2CH2I Telomer B Iodide Forafac® AFFF Agents Polymers > 80% of all
Slide 4: Perfluorocarboxylic Acids Indirect Sources
Perfluorocarboxylic Acids SHK 10June2005 INDIRECT SOURCES Telomerization Includes all global manufacturers CF2=CF2 TFE • Fluorotelomer-Based Products – PFCA Impurities, <1 to 100ppm F(CF2CF2)nI Telomer A n=4 – Degradation in the Environment n=3-6 C7F15CO2H (PFOA) • Raw Materials/Residuals F(CF2CF2)n
Slide 5: Telomer-Based Product Manufacturing Processes
SHK 10June2005 DuPont Telomer-Based Product Manufacturing Processes • U.S. EPA process prompted a comprehensive evaluation in 2003 • PFOA is neither used nor added in the manufacture of DuPont Telomer-Based Products – Research revealed trace PFOA impurity levels as an unintended reaction by-product
Slide 6: Employee Health Study
SHK 10June2005 DuPont Employee Health Study To date, no human health effects are known to be caused by PFOA • Studied 1,025 employees at DuPont W.Va. plant who have been exposed to PFOA • Phase 1 results Jan.’05; Phase 2 in progress, complete mid ‘05 • Studied 62 end points – blood serum and urine d
Slide 7: Implications of Health Study Beyond Plant
SHK 10June2005 Implications of Health Study Beyond Plant Not a general public health issue: - Associations were only seen in an occupational setting at highest decile level - PFOA levels in general public extremely low
Slide 8: Consumer Articles Study and Safety
SHK 10June2005 Consumer Articles Study and Safety A new scientific study sponsored by DuPont has reaffirmed that consumer articles made with the company’s materials are safe to use. The study reaffirms that there is no risk to consumers from potential exposure to trace levels of PFOA. -Consumer Arti
Slide 9: Forafac 1157 Developmental Toxicity Study
SHK 10June2005 Forafac® 1157 Developmental Toxicity Study • Study completed March 2005 • Oral dosages of 1157 solids to time-mated female rats • Dosing during gestation days 6-20 • Dosage levels were 0, 25, 150, and 1000 mg/kg/day • During in-life phases measured maternal body weights, food consumpt
Slide 10: Forafac 1157 Developmental Toxicity Study Results
SHK 10June2005 Forafac® 1157 Developmental Toxicity Study • Results – Maternal toxicity no observed effect level (NOEL) is 150 mg/kg/day based on body weight gain reduction at 1000 mg/kg/day – Fetal developmental toxicity NOEL is 1000 mg/kg/day, the highest dose level tested • Conclusion – Forafac®
Slide 11: Proposed Approach on Biodegradation of Fluorotelomer Products
SHK 10June2005 DuPont Proposed Approach on Biodegradation of Fluorotelomer Products Work in Progress • It is important to determine if fluorotelomer products contribute to PFOA exposure through environmental biodegradation. • DuPont is committed to: – Peer reviewed studies to determine if our new or
Slide 12: Telomer-based Surfactants & Polymers Biodegradation Studies
SHK 10June2005 DuPont Telomer-based Surfactants & Polymers Biodegradation Studies Respiration Inhibition Test Studies Underway Ready Biodegradation Ready Biodegradation Screening Studies Screening Studies Screening Studies Forafac® 1157 Ethoxylate and Phosphate Surfactants Acrylate and Urethane Surf
Slide 13: Polymer Biodegradation Studies
SHK 10June2005 Polymer Biodegradation Studies • Sludge – 28-Day Ready Biodegradation (OECD 301 B/D) – 28-Day Inherent Biodegradation (OECD 302 B) • Work complete, Analysis and reports in-progress – No evidence of polymer degradation • 28-Day Soil Screening Studies (completed Feb, 2005) – Soil : Aero
Slide 14: Forafac 1157 Degradation Study Status
SHK 10June2005 Forafac® 1157 Degradation Study Status • Contract laboratory identified and under contract – Forafac® 1157 studies are in queue • Requisite analyte(s) i.e. 6:2 sulfonate, and soil/sludge/sediment matrix analytical development underway – Time frame: 2-4 months • Conduct OECD degradatio
Slide 15: Life-Cycle Product Stewardship
SHK 10June2005 DuPont “Life-Cycle” Product Stewardship Carpet, Textiles, Paper Product Disposal Industrial Use Consumer Use Manufacture Environmental Fate Mill Pilot & Treated Article Product Release & Emissions Study Emissions Study Aging Distribution Environmental In-Use Product Analysis Environme
Slide 16: Presentation Summary
SHK 10June2005 Presentation Summary • Next Generation Fluorotelomers from DuPont – Our next generation fluorotelomers will dramatically reduce PFOA, other trace by-products, potential precursors, and thus reduce the potential for emissions. • The DuPont Consumer Article Study exposure assessment and
Slide 17: Presentation Summary
SHK 10June2005 Presentation Summary • DuPont has undertaken an extensive set of degradation testing to better inform the environmental fate of our products – DuPont has commissioned creation of a Global Degradation Exposure Model to better analyze the data forthcoming from its degradation studies –
Slide 18: Discussion and Questions
SHK 10June2005 Discussion and Questions